Jazz Pharmaceuticals plc (NASDAQ:JAZZ) currently has a daily average trading volume of 1.11M but it saw 327049 shares traded in last market. With a market cap of 6.62B USD, the company’s current market price of $109.45 came falling about -0.43 while comparing to the previous closing price of $109.92. In past 52 weeks, the stock remained buoying in the range of price level as high as $148.06 and as low as $95.49. In the recent trading on the day, stock has struck highest price mark of $109.12 while lowest mark touched by it was $110.04.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the UBS which upgraded the stock as “Buy” in its note to investors issued on March 07, 2025, recommending a price target of between $145 and $179 for it. Wells Fargo also issued its recommendations for the stock as it upgraded the price target for the stock in the range of between $130 and $170.
Over the week, JAZZ’s stock price is moving 1.80% up while it is -0.79% when we observe its performance for the past one month. Year-to-date it is 2.80% up and over the past year, the stock is showing a downside performance of -11.12%.
Currently, Jazz Pharmaceuticals plc’s total number of outstanding shares is 61.62M. Company’s return on investment (ROI) stands at 5.05% and return on equity (ROE) at 12.25%. It has a price to earnings ratio (P/E ratio) of 14.76 while having a 5.08 of forward P/E ratio. Stock’s beta reads 0.33. Stock has a price to book (P/B) ratio of 1.62 while price to sale or P/S ratio amounts to 1.63. Its return on asset (ROA) is 4.22% on average.
